Related Experiment Video
Updated: Jul 4, 2026
11:14
Mass Spectrometric Approaches to Study Protein Structure and Interactions in Lyophilized Powders
Published on: April 14, 2015
Retail pharmacy market structure and performance.
John M Brooks1, William R Doucette, Shaowei Wan
1University of Iowa College of Pharmacy, Iowa City, IA 52242, USA. john-brooks@uiowa.edu
Summary
Local retail pharmacy market structures may influence prescription drug use, services, and prices. This paper explores research to understand these pharmacy outcomes and market dynamics.
Area of Science:
- Health Services Research
- Pharmaceutical Economics
Background:
- Significant variation exists in prescription drug utilization, retail pharmacy services, and prescription costs.
- The impact of local retail pharmacy market structures on these outcomes remains unclear.
Purpose of the Study:
- To explore potential research avenues investigating the relationship between retail pharmacy market structures and pharmacy outcomes.
- To provide background on the retail pharmacy sector within the pharmaceutical supply chain.
Main Methods:
- Discussion of available data for analyzing retail pharmacy markets and outcomes.
- Identification of potential measures derivable from available data.
- Review of existing research findings and knowledge gaps.
Main Results:
- Identified variations in prescription drug use, pharmacy services, and prices.
- Highlighted the lack of clarity on the influence of market structure on these variations.
- Outlined data sources and measurement strategies for future research.
Conclusions:
- Further research is needed to understand how retail pharmacy market structures affect prescription drug use, services, and prices.
- The paper identifies key areas for investigation and data requirements.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:11Drug Distribution: Overview
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Initially, the free drug in the...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).